|  | Prevalence of Microangiopathy |  | ||||
---|---|---|---|---|---|---|---|
Variables | Groups | Duration (0-10 years) | p | Duration (11-20 years) | p | Duration (> 20 years) | p |
Overall | Â | Â | Â | Â | Â | Â | Â |
Retinopathy | MS Absent | 48 (28.2) | < 0.0001 | 25 (34.7) | 0.013 | 6 (46.2) | 1.000 |
 | MS Present | 122 (71.8) |  | 47 (65.3) |  | 7 (53.8) |  |
Nephropathy | MS Absent | 61 (29.6) | < 0.0001 | 12 (22.6) | < 0.0001 | 3 (60.0) | 1.000 |
 | MS Present | 145 (70.4) |  | 41 (77.4) |  | 2 (40.0) |  |
Neuropathy | MS Absent | 38 (19.9) | < 0.0001 | 18 (31.0) | 0.005 | 7 (46.7) | 1.000 |
 | MS Present | 153 (80.1) |  | 40 (69.0) |  | 8 (53.3) |  |
Men | Â | Â | Â | Â | Â | Â | Â |
Retinopathy | MS Absent | 36 (34.3) | 0.002 | 19 (43.2) | 0.451 | 6 (66.7) | 0.508 |
 | MS Present | 69 (65.7) |  | 25 (56.8) |  | 3 (33.3) |  |
Nephropathy | MS Absent | 46 (43.4) | 0.206 | 11 (36.7) | 0.200 | 3 (60.0) | 1.000 |
 | MS Present | 60 (56.6) |  | 19 (63.3) |  | 2 (40.0) |  |
Neuropathy | MS Absent | 24 (24.2) | < 0.0001 | 16 (40.0) | 0.268 | 6 (60.0) | 0.754 |
 | MS Present | 75 (75.8) |  | 24 (60.0) |  | 4 (40.0) |  |
Women | Â | Â | Â | Â | Â | Â | Â |
Retinopathy | MS Absent | 12 (18.5) | < 0.0001 | 6 (21.4) | 0.004 | 0 (0.0) | 0.125 |
 | MS Present | 53 (81.5) |  | 22 (78.6) |  | 4 (100.0) |  |
Nephropathy | MS Absent | 15 (15.0) | < 0.0001 | 1 (4.3) | < 0.0001 | 0 (0.0) | NA |
 | MS Present | 85 (85.0) |  | 22 (95.7) |  | 0 (0.0) |  |
Neuropathy | MS Absent | 14 (15.2) | < 0.0001 | 2 (11.1) | 0.001 | 1 (20.0) | 0.375 |
 | MS Present | 78 (84.8) |  | 16 (88.9) |  | 4 (80.0) |  |